Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026)

Vertex Pharmaceuticals' (VRTX) quarterly Prepaid Assets came in at $720.8 million in Q1 2026, up 12.13% year-on-year from $642.8 million in Q1 2025, and down 15.53% quarter-over-quarter from $853.3 million in Q4 2025.

Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $720.8 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 12.13% year-over-year to $720.8 million in Q1 2026; TTM through Mar 2026 was $720.8 million, a 12.13% increase from a year earlier, with the FY2025 full-year figure at $853.3 million, up 28.18% from the prior year.
  • Prepaid Assets fell to $720.8 million in Q1 2026 per VRTX's latest filing, from $853.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $853.3 million in Q4 2025 and bottomed at $84.3 million in Q4 2023.
  • The 5-year median for Prepaid Assets is $553.5 million (2022), against an average of $568.9 million.
  • Across the five-year window, Prepaid Assets slumped 84.77% in 2023 and soared 689.68% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $553.5 million in 2022, then slumped by 84.77% to $84.3 million in 2023, then surged by 689.68% to $665.7 million in 2024, then rose by 28.18% to $853.3 million in 2025, then slipped by 15.53% to $720.8 million in 2026.
  • Per Business Quant, the three latest VRTX Prepaid Assets figures stand at $720.8 million (Q1 2026), $853.3 million (Q4 2025), and $709.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 720.80 Mn
Dec 31, 2025 853.30 Mn
Sep 30, 2025 709.40 Mn
Jun 30, 2025 652.30 Mn
Mar 31, 2025 642.80 Mn
Dec 31, 2024 665.70 Mn
Sep 30, 2024 449.20 Mn
Jun 30, 2024 575.40 Mn
Mar 31, 2024 511.10 Mn
Dec 31, 2023 84.30 Mn
Sep 30, 2023 540.20 Mn
Jun 30, 2023 476.90 Mn
Mar 31, 2023 468.70 Mn
Dec 31, 2022 553.50 Mn
Sep 30, 2022 726.90 Mn
Jun 30, 2022 549.50 Mn
Mar 31, 2022 491.50 Mn
Dec 31, 2021 545.80 Mn
Sep 30, 2021 457.83 Mn
Jun 30, 2021 498.76 Mn